135 related articles for article (PubMed ID: 38650494)
1. Melanoma epidemiology in Europe: what is new?
Nurla LA; Forsea AM
Ital J Dermatol Venerol; 2024 Apr; 159(2):128-134. PubMed ID: 38650494
[TBL] [Abstract][Full Text] [Related]
2. Melanoma Epidemiology and Early Detection in Europe: Diversity and Disparities.
Forsea AM
Dermatol Pract Concept; 2020 Jul; 10(3):e2020033. PubMed ID: 32642304
[TBL] [Abstract][Full Text] [Related]
3. Disparities in melanoma incidence and mortality in South-Eastern Europe: Increasing incidence and divergent mortality patterns. Is progress around the corner?
Barbaric J; Sekerija M; Agius D; Coza D; Dimitrova N; Demetriou A; Safaei Diba C; Eser S; Gavric Z; Primic-Zakelj M; Zivkovic S; Zvolsky M; Bray F; Coebergh JW; Znaor A
Eur J Cancer; 2016 Mar; 55():47-55. PubMed ID: 26773419
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of Skin Cancer: Update 2019.
Leiter U; Keim U; Garbe C
Adv Exp Med Biol; 2020; 1268():123-139. PubMed ID: 32918216
[TBL] [Abstract][Full Text] [Related]
6. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015.
Arnold M; Holterhues C; Hollestein LM; Coebergh JW; Nijsten T; Pukkala E; Holleczek B; Tryggvadóttir L; Comber H; Bento MJ; Diba ChS; Micallef R; Primic-Žakelj M; Izarzugaza MI; Perucha J; Marcos-Gragera R; Galceran J; Ardanaz E; Schaffar R; Pring A; de Vries E
J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1170-8. PubMed ID: 23962170
[TBL] [Abstract][Full Text] [Related]
7. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia.
de Vries E; Bray FI; Coebergh JW; Parkin DM
Int J Cancer; 2003 Oct; 107(1):119-26. PubMed ID: 12925966
[TBL] [Abstract][Full Text] [Related]
8. Melanoma epidemiology and trends.
Garbe C; Leiter U
Clin Dermatol; 2009; 27(1):3-9. PubMed ID: 19095149
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
10. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe.
Mallone S; De Vries E; Guzzo M; Midena E; Verne J; Coebergh JW; Marcos-Gragera R; Ardanaz E; Martinez R; Chirlaque MD; Navarro C; Virgili G;
Eur J Cancer; 2012 May; 48(8):1167-75. PubMed ID: 22119735
[TBL] [Abstract][Full Text] [Related]
11. A Reminder of Skin Cancer During the COVID-19 Pandemic.
Šitum M; Filipović N; Buljan M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
[TBL] [Abstract][Full Text] [Related]
12. More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.
Kandolf Sekulovic L; Peris K; Hauschild A; Stratigos A; Grob JJ; Nathan P; Dummer R; Forsea AM; Hoeller C; Gogas H; Demidov L; Lebbe C; Blank C; Olah J; Bastholt L; Herceg D; Neyns B; Vieira R; Hansson J; Rutkowski P; Krajsova I; Bylaite-Bucinskiene M; Zalaudek I; Maric-Brozic J; Babovic N; Banjin M; Putnik K; Weinlich G; Todorovic V; Kirov K; Ocvirk J; Zhukavets A; Kukushkina M; De La Cruz Merino L; Ymeri A; Risteski M; Garbe C
Eur J Cancer; 2017 Apr; 75():313-322. PubMed ID: 28264791
[TBL] [Abstract][Full Text] [Related]
13. Melanoma incidence and mortality in Europe: new estimates, persistent disparities.
Forsea AM; Del Marmol V; de Vries E; Bailey EE; Geller AC
Br J Dermatol; 2012 Nov; 167(5):1124-30. PubMed ID: 22759278
[TBL] [Abstract][Full Text] [Related]
14. Melanoma prognosis in Europe: far from equal.
Forsea AM; Del Marmol V; Stratigos A; Geller AC
Br J Dermatol; 2014 Jul; 171(1):179-82. PubMed ID: 24588115
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of skin cancer.
Leiter U; Eigentler T; Garbe C
Adv Exp Med Biol; 2014; 810():120-40. PubMed ID: 25207363
[TBL] [Abstract][Full Text] [Related]
16. Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in Europe.
Maul LV; Jamiolkowski D; Lapides RA; Mueller AM; Hauschild A; Garbe C; Lorigan P; Gershenwald JE; Ascierto PA; Long GV; Wang-Evers M; Scolyer RA; Saravi B; Augustin M; Navarini AA; Legge S; Németh IB; Jánosi ÁJ; Mocellin S; Feller A; Manstein D; Zink A; Maul JT; Buja A; Adhikari K; Roider E
JAMA Netw Open; 2024 Feb; 7(2):e2356479. PubMed ID: 38363565
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous melanoma.
Armstrong BK; Kricker A
Cancer Surv; 1994; 19-20():219-40. PubMed ID: 7534627
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight.
Leiter U; Garbe C
Adv Exp Med Biol; 2008; 624():89-103. PubMed ID: 18348450
[TBL] [Abstract][Full Text] [Related]
19. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe.
de Vries E; Boniol M; Doré JF; Coebergh JW;
Eur J Cancer; 2004 May; 40(7):1045-52. PubMed ID: 15093581
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology on malignant melanoma in Europe.
Osterlind A
Acta Oncol; 1992; 31(8):903-8. PubMed ID: 1290637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
